Lataa...

Is There a Role for Minimal Residual Disease Monitoring in Follicular Lymphoma in the Chemo-Immunotherapy Era?

After 25 years, evaluation of minimal residual disease (MRD) in follicular lymphoma (FL) has become a standardized technique frequently integrated into clinical trials for its consistent and independent prognostic significance. Achievement of a sustained MRD negativity is a marker of treatment sensi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mediterr J Hematol Infect Dis
Päätekijät: Gritti, Giuseppe, Pavoni, Chiara, Rambaldi, Alessandro
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Università Cattolica del Sacro Cuore 2017
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5224815/
https://ncbi.nlm.nih.gov/pubmed/28101314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2017.010
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!